Appetite suppressant compositions and methods thereof
AssigneeRed Mountain Med Spa, LLC
InventorSuzanne Bentz
Life of this patent
Estimating the term…
Abstract
An appetite suppressant composition may comprise at least one anorectic active ingredient; at least one of a nutritive substance, a cofactor; and optionally, an excipient. The anorectic active ingredient may comprise any one of phentermine, phendimetrazine, diethylpropion, naltrexone, and bupropion. The nutritive substance may comprise a protein source such as bovine collagen. The cofactor may comprise a chromium or selenium salt. In various embodiments, the compositions herein are provided in an oral capsule dosage form for GI-tract administration of the AAI. A method of suppressing appetite in individuals in need thereof are described.
Claims12
An appetite suppressant composition consisting essentially of:
- from 12.0 wt. % to 18.0 wt. % phendimetrazine tartrate;
- from 80.0 wt. % to 90.0 wt. % bovine collagen;
- and
- from 0.05 wt. % to 0.10 wt. % chromium picolinate.
An appetite suppressant composition consisting essentially of:
- from 6.0 wt. % to 12.0 wt. % diethylpropion-HCl, said diethylpropion-HCl including 1% tartaric acid;
- from 50.0 wt. % to 58.0 wt. % bovine collagen;
- and
- from 0.05 wt. % to 0.10 wt. % chromium picolinate.
Dependencies are inferred from the claim text.